SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro

Int J Mol Sci. 2022 Mar 21;23(6):3394. doi: 10.3390/ijms23063394.

Abstract

Growing cases of patients reported have shown a potential relationship between (severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 infection and Parkinson's disease (PD). However, it is unclear whether there is a molecular link between these two diseases. Alpha-synuclein (α-Syn), an aggregation-prone protein, is considered a crucial factor in PD pathology. In this study, bioinformatics analysis confirmed favorable binding affinity between α-Syn and SARS-CoV-2 spike (S) protein and nucleocapsid (N) protein, and direct interactions were further verified in HEK293 cells. The expression of α-Syn was upregulated and its aggregation was accelerated by S protein and N protein. It was noticed that SARS-CoV-2 proteins caused Lewy-like pathology in the presence of α-Syn overexpression. By confirming that SARS-CoV-2 proteins directly interact with α-Syn, our study offered new insights into the mechanism underlying the development of PD on the background of COVID-19.

Keywords: Parkinson’s disease; SARS-CoV-2; alpha-synuclein; nucleocapsid protein; spike protein.

MeSH terms

  • COVID-19*
  • HEK293 Cells
  • Humans
  • Lewy Bodies / metabolism
  • Parkinson Disease* / metabolism
  • SARS-CoV-2
  • alpha-Synuclein / metabolism

Substances

  • SNCA protein, human
  • alpha-Synuclein